Recent Quotes (30 days)

You have no recent quotes
chg | %

Abaco Capital PLC  

(Public, LON:ABA)   Watch this stock  
Find more results for ABA
1.40
-0.08 (-5.08%)
Jan 16 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1.40 - 1.40
52 week 1.12 - 3.61
Open 1.40
Vol / Avg. 138,505.00/252,749.00
Mkt cap 21.28M*
P/E     -
Div/yield     -
EPS 0.00*
Shares 1.21B
Beta     -
Inst. own     -
*GBP
Mar 8, 2018
Full Year 2017 Oxford Pharmascience Group PLC Earnings Release (Estimated) Add to calendar
  

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -318.12% -173.87%
Operating margin -331.76% -255.03%
EBITD margin - -253.77%
Return on average assets -12.18% -5.91%
Return on average equity -12.30% -5.97%
Employees 10 -
CDP Score - -

Address

Camden, 2 Royal College Street
LONDON, NW1 0NH
United Kingdom - Map
+44-20-75545875 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Abaco Capital plc, formerly Oxford Pharmascience Group plc, is a United Kingdom-based shell company. The Company is seeking for the investment opportunities in any sector. The Company has no operations.

Officers and directors

Marcelo Leonardo Bravo Chief Executive Officer, Executive Director
Christopher Hill Chief Financial Officer, Executive Director, Company Secretary
David Robert Norwood Non-Executive Chairman of the Board
Age: 48
James Nicholas Gerald White Non-Executive Deputy Chairman of the Board
John Geoffery Goddard Independent Non-Executive Director
Karl Robertson Van Horn Independent Non-Executive Director
Age: 80